3,4-MDiPA HCl | analytical reference standard | amphetamine | CAS#74341-76-7

MedKoo Cat#: 128377 | Name: 3,4-MDiPA HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

3,4-MDiPA (hydrochloride) is an analytical reference standard categorized as an amphetamine.

Chemical Structure

3,4-MDiPA HCl

CAS#74341-76-7

Theoretical Analysis

MedKoo Cat#: 128377

Name: 3,4-MDiPA HCl

CAS#: 74341-76-7

Chemical Formula: C13H20ClNO2

Exact Mass: 0.0000

Molecular Weight: 257.76

Elemental Analysis: C, 60.58; H, 7.82; Cl, 13.75; N, 5.43; O, 12.41

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

3,4-MDiPA HCl; 3,4-MDiPA (hydrochloride); 3,4-MDiPr; 3,4-Methylenedioxy-N-isopropylamphetamine; N-isopropyl MDA

IUPAC/Chemical Name

1-(benzo[d][1,3]dioxol-5-yl)-N-isopropylpropan-2-amine hydrochloride

InChi Key

IQKXMWWDHAZTPZ-UHFFFAOYSA-N

InChi Code

InChI=1S/C13H19NO2.ClH/c1-9(2)14-10(3)6-11-4-5-12-13(7-11)16-8-15-12;/h4-5,7,9-10,14H,6,8H2,1-3H3;1H

SMILES Code

CC(C)NC(C)CC1=CC(OCO2)=C2C=C1.Cl

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 257.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Li G, Chen J, Xie Y, Yang Y, Niu Y, Chen X, Zeng X, Zhou L, Liu Y. White light increases anticancer effectiveness of iridium(III) complexes toward lung cancer A549 cells. J Inorg Biochem. 2024 Oct;259:112652. doi: 10.1016/j.jinorgbio.2024.112652. Epub 2024 Jun 26. PMID: 38945112. 2: Shen Y, Fouse SD, Fan G. Genome-wide DNA methylation profiling: the mDIP-chip technology. Methods Mol Biol. 2009;568:203-16. doi: 10.1007/978-1-59745-280-9_13. PMID: 19582429. 3: Lee DH, Jin Q, Shi N, Wang F, Bever AM, Liang L, Hu FB, Song M, Zeleznik OA, Zhang X, Joshi A, Wu K, Jeon JY, Meyerhardt JA, Chan AT, Eliassen AH, Clish C, Clinton SK, Giovannucci EL, Li J, Tabung FK. The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes. Diabetologia. 2024 Jan;67(1):88-101. doi: 10.1007/s00125-023-06021-3. Epub 2023 Oct 11. PMID: 37816982; PMCID: PMC11555568. 4: Nandi S, Mansouri A, Dovgaliuk I, Boullay P, Patriarche G, Cornu I, Florian P, Mouchaham G, Serre C. A robust ultra-microporous cationic aluminum-based metal-organic framework with a flexible tetra-carboxylate linker. Commun Chem. 2023 Jul 6;6(1):144. doi: 10.1038/s42004-023-00938-x. PMID: 37414866; PMCID: PMC10326013. 5: Rodrigues MV, Borges N, Almeida CP, Lamosa P, Santos H. A unique beta-1,2-mannosyltransferase of Thermotoga maritima that uses di-myo-inositol phosphate as the mannosyl acceptor. J Bacteriol. 2009 Oct;191(19):6105-15. doi: 10.1128/JB.00598-09. Epub 2009 Jul 31. PMID: 19648237; PMCID: PMC2747880. 6: Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, Kurihara H, Mitsuya M, Ohkubo M, Ohta H. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. J Pharmacol Exp Ther. 2007 Oct;323(1):147-56. doi: 10.1124/jpet.107.124701. Epub 2007 Jul 3. PMID: 17609420. 7: Tang H, Arnold RJ, Alves P, Xun Z, Clemmer DE, Novotny MV, Reilly JP, Radivojac P. A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics. 2006 Jul 15;22(14):e481-8. doi: 10.1093/bioinformatics/btl237. PMID: 16873510. 8: Li Y , Chang Z , Huang F , Wu P , Chu H , Wang J . A bi-metallic MOF catalyst via sensitive detection & adsorption of Fe³⁺ ions for size-selective reaction prompting. Dalton Trans. 2018 Jul 17;47(28):9267-9273. doi: 10.1039/c8dt01145a. PMID: 29790543. 9: Montes RO. Frequentist and Bayesian tolerance intervals for setting specification limits for left-censored gamma distributed drug quality attributes. Pharm Stat. 2024 Mar-Apr;23(2):168-184. doi: 10.1002/pst.2344. Epub 2023 Oct 23. PMID: 37871968. 10: Iacobazzi V, Castegna A, Infantino V, Andria G. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab. 2013 Sep-Oct;110(1-2):25-34. doi: 10.1016/j.ymgme.2013.07.012. Epub 2013 Jul 19. PMID: 23920043.